Mereo BioPharma Group

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.

About MREO

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).

CEO

Denise Vera Scots-Knight

CEODenise Vera Scots-Knight

Employees

Employees36

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2015

Founded2015

Employees

Employees36

MREO Key Statistics

Market cap

432.48M

Market cap432.48M

Price-Earnings ratio

-8.53

Price-Earnings ratio-8.53

Dividend yield

—

Dividend yield—

Average volume

1.23M

Average volume1.23M

High today

$2.76

High today$2.76

Low today

$2.63

Low today$2.63

Open price

$2.68

Open price$2.68

Volume

723.03K

Volume723.03K

52 Week high

$5.02

52 Week high$5.02

52 Week low

$1.58

52 Week low$1.58

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell